Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neurologic Manifestations × Sildenafil Citrate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Neurologic Manifestations 1 Glioma 1 Glioblastoma 1 Erectile Dysfunction 1 Brain Neoplasms 1

Interventions

Temozolomide 2 Bevacizumab 2 Valproic Acid 1 Therapeutics 1 Sorafenib 1 Sildenafil Citrate 1 Radiotherapy 1 Irinotecan 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01817751 2024-07-17

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Virginia Commonwealth University

Phase 2 Completed

47 enrolled 13 charts

Brain Neoplasms, Glioblastoma, Glioma, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡